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OBJECTIVES To compare stenting of aortic arch vessel obstruction with surgical therapy and to establish
recommendations for treatment.
BACKGROUND Though surgery has been considered to be the procedure of choice for subclavian and
brachiocephalic obstruction, little work has been done to compare it with stenting.
METHODS Eighteen patients with symptomatic aortic arch vessel stenosis or occlusion were treated with
stenting, followed by periodic clinical follow-up and noninvasive arterial Doppler studies.
Data were compared with the results as shown in a systematic review of a published series of
surgery and stenting procedures which included comparison of technical success, complica-
tions, mortality and patency.
RESULTS Primary success in our series was 100% with improvement in mean stenosis from 84 6 11%
to 1 6 5% and mean arm systolic blood pressure difference from 44 6 16 mm Hg to 3 6
3 mm Hg. There were no major complications (death, stroke, TIA, stent thrombosis or
myocardial infarction). At follow-up (mean 17 months), all patients were asymptomatic with
100% primary patency. Literature review demonstrates equivalent patency and complications
in the other published series of stenting. In contrast, there was a similar patency but overall
incidence of stroke of 3 6 4% and death of 2 6 2% in the published surgical series.
CONCLUSIONS Subclavian or brachiocephalic artery obstruction can be effectively treated by primary stenting
or surgery. Comparison of stenting and the surgical experience demonstrates equal effective-
ness but fewer complications and suggests that stenting should be considered as first line
therapy for subclavian or brachiocephalic obstruction. (J Am Coll Cardiol 1999;33:1238–45)
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Brachiocephalic or subclavian artery obstructions account
for approximately 17% of symptomatic extracranial cerebro-
vascular disease (1,2) and are an important cause of mor-
bidity associated with a variety of symptoms. Subclavian
steal syndrome arises when flow reversal occurs in the
vertebral artery thereby shunting blood away from the brain
and into the brachial circulation (1,3,4) resulting in the
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symptoms of vertebrobasilar insufficiency (2,5). Upper ex-
tremity ischemic symptoms may occur as a result of ipsilat-
eral claudication related to arm exercise or from emboliza-
tion of the digits (6). In coronary-subclavian steal there is a
proximal subclavian stenosis causing reversal of flow in an
internal mammary artery graft and ischemia of the myocar-
dium it supplies (7–10). The prevalence of subclavian artery
stenosis in patients undergoing myocardial revascularization
is approximately 0.5% to 1.1% (10–12). Similarly, patients
who undergo axillofemoral bypass surgery may have unre-
lieved claudication or graft compromise due to an unrecog-
nized proximal subclavian stenosis.
Although some patients may become asymptomatic
(13,14) with conservative therapy, the majority require relief
of the obstruction to alleviate symptoms. A variety of
surgical techniques have been developed including trans-
thoracic procedures, carotid-subclavian bypass and axilloax-
illary bypass (2,21–71). Over the years these surgical ap-
proaches have been considered “standard” therapy.
However, even with less invasive extraanatomic extratho-
racic reconstructions, the morbidity and mortality is signif-
icant (2,21–71).
Balloon angioplasty for subclavian artery stenosis was first
described in 1980 (15). Comparatively favorable initial
success and patency were achieved with rare complications
and mortality (15–20). The potential for distal embolization
and stroke, uncertain long-term patency and difficulty in
treating total occlusions remained a concern. Recognizing
improvements in anesthetic and operative technique, short
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hospital stays and early discharge, many practitioners con-
tinued to regard surgery as the standard therapy against
which endovascular methods must be compared.
Vascular stenting has reduced acute closure, diminished
distal embolization, improved medium term patency and
provided the ability to recanalize chronic total occlusions.
As a result, enthusiasm has developed for the use of vascular
stents as primary treatment for atherosclerotic obstructive
disease of branches of the aorta. Unfortunately, there have
been no randomized trials comparing percutaneous inter-
ventions with surgery for treatment of aortic arch vessel
disease. This report describes what is known about surgical
treatment outcomes and compares these results with our
experience in using of the Palmaz stent for the primary
treatment of patients with symptomatic subclavian or bra-
chiocephalic artery obstruction.
METHODS
Patients. All patients referred to the Interventional Car-
diovascular Medicine Service between November 1994 and
March 1998 were screened for the presence of symptomatic
brachiocephalic or subclavian artery obstruction. Eighteen
persistently symptomatic patients who required revascular-
ization were identified. A percutaneous treatment approach
was chosen in all 18, including 4 with total occlusions. Table
1 summarizes the baseline clinical characteristics of these
patients.
Symptoms were classified according to the following
scheme: neurological manifestations of subclavian steal
comprised the syndrome of vertebrobasilar ischemia with
ipsilateral retrograde vertebral artery blood flow in the
presence of subclavian or brachiocephalic occlusive disease
proximal to the origin of the vertebral artery. In patients in
whom the internal mammary artery had been used for
coronary bypass, myocardial ischemia was attributed to
subclavian-coronary steal if the origin of the artery was
distal to the subclavian obstruction and there were no other
angiographic coronary obstructive lesions that might ac-
count for the symptoms; in addition, coronary angiography
revealed retrograde filling of the internal mammary artery.
Upper extremity ischemia, occurring in seven patients, was
manifest by severe exertional arm claudication (n 5 5) or
clinical evidence of digit emboli (n 5 2). There was one
patient who underwent axillofemoral bypass surgery for
critical lower limb ischemia but had persisting graft inflow
obstruction because of a severe proximal right subclavian
artery stenosis.
All patients underwent clinical evaluation and noninva-
sive vascular assessment with a Doppler ultrasound study of
the brachiocephalic vessels including measurement of the
brachiobrachial index (the ratio of the systolic pressure of
the affected arm over that of the opposite arm). The index
can only be calculated if the contralateral “normal” arm
shows no Doppler evidence of obstruction. Carotid duplex
scanning was performed to detect other extracranial vessel
involvement and to determine the direction of flow in the
vertebral arteries at rest.
Before revascularization nine patients were pretreated
with 325 mg of aspirin daily in combination with 250 mg of
Ticlopidine twice daily; five patients received aspirin alone.
Four patients were receiving long-term warfarin (for indi-
cations unrelated to stenting) and this was reinstituted (in
combination with aspirin) following the procedure.
Revascularization procedures. Using standard catheter-
ization techniques, arterial access was obtained (femoral 12,
brachial 2, radial 1 and femoral-brachial 3). Aortic arch and
selective angiography were performed in at least two views
that displayed the lesion. Intravenous heparin was admin-
istered during the procedure to maintain the activated
clotting time in the range of 200 to 300 s. An appropriate
guiding catheter was chosen and the stenosis crossed with
an 0.0180 guidewire. Predilatation was accomplished using a
balloon undersized by 1–2 mm.
In the case of total occlusions, the obstructions were
Abbreviations and Acronyms
MLD 5 minimal luminal diameter
RD 5 reference diameter
Table 1. Demographic, Clinical and Angiographic
Characteristics of Patients Treated With Stents
Number %
Patient Characteristics
Men 8 44
Women 10 56
Mean age (yrs) 64 –
(Range) 47–81 –
Hypertension 11 61
Diabetes 8 44
Hypercholesterolemia 10 56
Smoker 12 67
Carotid artery disease 6 33
Coronary artery disease 14 78
Prior coronary bypass 9 50
Lower limb claudication 9 50
Presenting Symptoms
Subclavian steal 7 39
Arm ischemia 7 39
Coronary-subclavian steal 7 39
Graft inflow compromise 1 6
Lesion Site
Left subclavian 12 66
Right subclavian 3 17
Brachiocephalic 3 17
Treated segments
Total occlusions 4 22
Stenoses 14 78
Mean stenosis (%) 83 –
Range (%) 70–100 –
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traversed using 0.035 to 0.030 Glidewires (Meditech, Bos-
ton Scientific Inc., Natick, Massachusetts) over which were
passed a 4 or 5 Fr Glidecath (Meditech, Boston Scientific
Inc., Natick, Massachusetts). The intravascular position of
the catheter was confirmed by contrast injection and a
0.0180 guidewire was then placed through the catheter.
Initial dilatations were carried out progressively beginning
with 4 mm balloons. All patients then received Palmaz
stents (P104, P154, P204, Johnson & Johnson Interven-
tional Systems) which were hand-crimped on balloons
estimated to be sized 1:1 to the reference segment. When
necessary, multiple stents were placed to cover the entire
stenosis. Following initial stent deployment, high-pressure
inflations (10–16 atm.) were performed. Final angiograms
were obtained in projections identical to those used initially.
All vascular sheaths were removed the same day as the
procedure.
Quantitative angiographic measurements were made in
the view showing the most severe disease. Digital calipers
were used to measure the reference diameter (RD) of the
nearest uninvolved segment and minimal luminal diameter
(MLD) of the diseased segment. The contrast-filled guiding
catheter was used for calibration. Percent stenosis is ex-
pressed as: [(RD 2 MLD)/RD] 3 100.
Follow-up with clinical evaluation and repeat noninvasive
arterial studies were planned within 1 to 6 weeks, at 6
months, at 12 months and subsequently at yearly intervals
after the procedure. The stented segment was judged to be
patent if there was no recurrence of symptoms, mean
systolic BP difference between the arms was ,10 mm Hg
and the stent velocity by Doppler increased by no more than
20% with an absolute measurement of ,200 cm/s.
Literature review and analysis. A Medline search was
performed to identify all papers and abstracts discussing
surgery for subclavian, brachiocephalic, cervical or aortic
arch vessels. The period searched encompassed 1966
through 1998. Over 300 citations were screened to identify
papers where the surgical treatment of obstructive athero-
sclerotic vascular disease was the primary focus. Each paper
was reviewed, and the references were screened for other
papers not previously identified in the Medline search.
Where multiple similarly authored papers included the same
series, the most recent or the one containing the largest
series was chosen. Single case reports were reviewed as
sources of other papers contained within their references but
were not included in the analysis.
Qualitative comparisons of the published surgical out-
comes and stent outcomes were made. Both the diagnostic
criteria in these collected series and the definitions of
“complications,” “minor complications” and “major compli-
cations” varied from series to series. Follow-up protocols,
criteria for symptom recurrence and the determination of
patency were often not stated. Therefore it was decided that
we would evaluate simpler but more uniformly reported
endpoints including technical success (the ability to perform
the planned procedure yielding target lesion revasculariza-
tion and survival to discharge), patient death, stroke and
patency of the treated segment.
RESULTS
Current series. There were 18 treated segments (4 occlu-
sions, 14 high-grade stenoses) in 18 patients with a mean
residual stenosis after stenting of 1 6 5% and appearance of
normal antegrade flow in the treated vessels. The prepro-
cedural minimal luminal diameter was 1.2 6 0.8 mm
increasing to 7.4 6 1.2 mm after stenting, for an acute gain
of 6.2 mm. Mean stent length was 27 6 14 mm (range 15
to 60 mm). The mean poststent balloon diameter was 8 6
1 mm (range 5 to 10 mm) with a mean inflation pressure of
16 atmospheres. A typical angiographic result illustrating
recanalization and stenting of a chronic total subclavian
occlusion is shown in Figure 1A and B. The systolic blood
pressure difference between the arms decreased from 44 6
16 mm Hg to 3 6 3 mm Hg (Fig. 2) and the brachiobra-
chial index increased from 0.70 6 0.11 to 0.98 6 0.02. All
18 patients reported complete relief of their presenting
symptoms.
There were no major complications (death, stroke, tran-
sient ischemic attacks, myocardial infarction, stent throm-
bosis or occlusion). An access site pseudoaneurysm devel-
oped in one patient; this was successfully compressed using
ultrasound guidance. Stent embolization occurred in one
patient; the stent was withdrawn to the femoral artery and
then surgically retrieved.
During the 1 to 48 month follow-up (mean 17 months),
symptomatic restenoses did not occur and the brachiobra-
chial gradient did not change (Fig. 2.) All Doppler studies
were consistent with widely patent vessels. One patient died
12 months after intervention from causes unrelated to her
procedure. There were no repeat interventions at the treated
segment, but two additional patients later underwent suc-
cessful stent placement to the iliac artery for symptomatic
lower limb ischemia.
Surgical review. Table 2 summarizes the 52 papers that
describe a total of 2,496 patients treated surgically. In these
reports, preprocedure symptoms, diagnostic evaluation and
concomitant medical illnesses were not consistently de-
scribed. The methods by which one procedure was chosen
over another were variable and the rationale for performing
(or not performing) associated carotid endarterectomy in
patients with combined carotid disease were not uniformly
stated. There were no prospective randomized trials com-
paring surgery with any other form of therapy or comparing
different surgical procedures.
The combined initial technical success rate is high (mean
96 6 5%, range 75% to 100%). Stroke occurred in 3 6 4%
(range 0% to 14%) and death in 2 6 2% (range 0% to 11%).
Adverse events of any kind were reported in 331 patients for
an overall complication rate of 16 6 11% (range 0% to 43%)
(2,21–71). When the review is limited to surgical series
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from the last ten years, complications occur in 13%, stroke
in 3% and death in 2% (57–71).
Reported surgical complications included stroke or tran-
sient ischemic attack, myocardial infarction, hemorrhage,
phrenic nerve palsy, Horner’s syndrome, delayed wound
healing, infection, graft thrombosis, lung atelectasis with
pneumonia, pleural effusions, chylothorax and others per-
taining to general anesthesia. Risk factors associated with
complications suggest that open-chest procedures are asso-
ciated with a higher mortality and morbidity than that of
extrathoracic bypass (2,23,27,71) and that current surgical
practice favors local bypass with synthetic conduit.
Follow-up was largely clinical in the surgical series and
while this may have been adequate to identify symptom
recurrence, it does not confirm patency of the treated
segments; the development of collaterals may mask the
brachiobrachial pressure differential of a stenosed or oc-
cluded bypass. Overall recurrence was reported in 268
patients (16 6 14%) at a mean follow-up of 51 6 25
months. Recurrence in surgical series reported in the last ten
years is 12%. Because Doppler evaluation is required to
confirm triphasic subclavian flow or graft patency in these
situations, these are largely clinical threshold recurrence
rates, and the true rates of restenosis or occlusion may be
higher.
Stent review. Table 3 summarizes the published series of
patients treated with stents. Of the 108 patients represented
in the reports (72–77), technical success was achieved in 105
(97 6 4%). Adverse events were reported in 7 patients (6 6
5%). In contrast to surgery, reported complications with
stenting were minor and limited to vascular access difficulty
and stent dislodgment, which was managed by deployment
at the iliac artery or by surgical retrieval of the stent via the
catheter entry site. No strokes or deaths were reported.
Follow-up data were available in 81 of 108 procedures at a
mean duration of 20 6 9 months. Recurrence (documented
reocclusion or restenosis) was reported in 3 6 5%.
DISCUSSION
Surgery as standard therapy. Before the advent of percu-
taneous techniques, surgical treatment for aortic arch vessel
obstruction was advocated with axilloaxillary and carotid-
subclavian bypass as the favored procedures due to relatively
low morbidity and mortality. Despite this, surgical proce-
Figure 1. (A) Aortic arch angiography demonstrates the stump of
a totally occluded left subclavian artery (arrow). (B) shows a
selective angiogram after recanalization and stenting. The arrows
(S) indicate the stented segment; (I) the internal mammary artery
and (V) the vertebral artery.
Figure 2. Brachiobrachial systolic blood pressure differences before
treatment, after stenting and at follow-up. The gradient is signif-
icantly reduced after stenting (p , 0.0001 by Student paired t test)
and remained unchanged between the immediate post stent value
and follow-up (p 5 0.12).
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Table 2. Summary of the Published Series of Surgical Treatment of Brachiocephalic and Subclavian Obstruction
Lead
Author Ref. Year
Patients
n
Technical
Success Stroke Complications Death Recurrence
Operation(s)n % n % n % n % n % F/U(mo)
Fields 2 1972 64 56 88 9 14 16 25 4 6 16 25 40 EAC,BYP,VL(TT)
Snider 21 1974 6 6 100 0 0 2 33 0 0 1 17 11 AAB
Hafner 22 1976 40 38 95 1 3 2 5 1 3 3 8 60 CSB,BYP,EAC(TT)
Luosto 23 1976 121 109 90 2 2 26 21 3 2 – 29 42 EAC(TT),BYP,TRP
Rich 24 1977 9 9 100 0 0 0 0 0 0 2 22 – EAC,CSB
Gross 25 1978 19 17 89 – – 4 21 2 11 4 24 43 CSB,BYP,EAC(TT)
Mehigan 26 1978 12 12 100 0 0 0 0 0 0 – – – TRP
Lilequist 27 1979 85 79 93 8 9 22 26 5 6 – 20 96 EAC,BYP(TT)
Myers 28 1979 20 18 90 2 10 4 20 0 0 3 14 36 AAB
Sodal 29 1979 11 10 91 1 9 1 9 0 0 2 18 29 EAC,BYP
Beebe 30 1980 35 35 100 0 0 8 23 0 0 2 6 22 EAC,BYB(TT),CSB,AAB
Raithel 31 1980 66 66 100 0 0 7 11 2 3 2 3 48 EAC(TT),BYP,CSB
Thompson 32 1980 90 81 90 1 1 14 16 3 3 11 15 – AAB,CSB,EAC(TT)
DePalma 33 1981 25 25 100 0 0 1 4 0 0 0 0 3 EAC(TT),CSB,AAB
Deriu 34 1981 34 31 91 2 6 3 9 1 3 4 13 6 EAC,BYP(TT),CSB
Dietrich 35 1981 11 11 100 0 0 0 0 0 0 – – – CST
Welling 36 1981 90 83 92 1 1 9 10 2 2 14 16 – AAB,CSB,EAC(TT)
Bentley 37 1982 10 10 100 0 0 0 0 0 0 2 20 45 AAB
Vogt 38 1982 100 94 94 2 2 9 9 5 5 18 18 52 CSB,AAB,EAC,BYP(TT)
Aburahma 39 1983 12 11 92 1 8 3 25 0 0 1 8 22 AAB,CSB
Aitken 40 1983 7 7 100 0 0 3 43 0 0 0 0 50 AAB
Crawford 41 1983 142 134 94 7 5 8 6 3 2 19 13 90 EAC,BYP(TT),AAB
Lerut 42 1983 33 32 97 1 3 13 39 0 0 – – – TRP
Posner 43 1983 27 27 100 0 0 2 2 0 0 0 0 26 AAB
Bleichrodt 44 1984 20 20 100 0 0 4 20 0 0 2 10 76 EAC(TT)
Dalton 45 1984 39 39 100 0 0 2 5 0 0 – – – CSB
Harris 46 1984 28 26 93 0 0 4 14 1 4 3 12 – CSB,BYP
Schlosser 47 1984 77 76 99 2 3 5 6 1 1 5 6 – CSB,EAC,BYP(TT)
Brewster 48 1985 37 36 97 2 5 3 8 1 3 6 16 50 EAC,BYP(TT),AAB
Welch 49 1985 28 26 93 0 0 6 21 1 4 2 8 – AAB,CSB,BYP
Chang 50 1986 41 40 98 – – – – – 2 3 7 – AAB
Shifrin 51 1986 11 11 100 0 0 2 18 0 0 2 18 38 AAB,CSB
Ziomek 52 1986 36 32 89 2 6 3 8 1 3 11 31 52 CSB
Schanzer 53 1987 33 32 97 0 0 1 3 1 3 – 28 60 AAB
Stipa 54 1987 16 12 75 – – – – 0 0 8 50 70 AAB
Weimann 55 1987 38 38 100 0 0 5 13 0 0 1 3 13 CSB
Weiner 56 1987 19 18 95 0 0 6 32 0 0 3 16 82 AAB
Coorbier 57 1988 215 – 91 – – – – 1 0.5 62 29 55 CSB,AAB
Rosenthal 58 1988 32 32 100 0 0 2 6 0 0 4 13 40 AAB
Farina 59 1989 15 13 87 0 0 4 27 0 0 2 87 60 CSB,TRP
Sterpeti 60 1989 46 46 100 2 4 7 15 0 0 4 9 47 CSB,TRP
Defraigne 61 1990 29 27 93 1 3 – – 1 3 1 3 40 CSB
Perler 62 1990 31 30 97 1 3 8 26 0 0 3 17 42 CSB,TRP
Branchereau 63 1991 97 94 95 4 4 5 5 1 1 10 10 54 EAC(TT),TRP,CSB,BYP
Kretschmer 64 1991 51 51 100 1 2 10 20 0 0 5 10 120 CSB,TRP
Mingoli 65 1992 43 43 100 2 5 11 26 0 0 11 26 66 CSB,AAB
Lowell 66 1993 10 10 100 1 10 2 20 0 0 2 20 85 AAB
Smith 67 1994 54 53 98 0 0 4 7 3 6 0 0 62 CSB,AAB,VL
Vitti 68 1994 124 124 100 0 0 11 9 1 1 3 6 92 CSB
Law 69 1995 51 50 98 2 4 12 24 1 2 – 12 60 CSB
Schardey 70 1996 108 108 100 2 2 16 15 0 0 11 13 70 TRP
Berguer 71 1998 98 96 98 10 10 41 41 8 8 – 12 51 EAC,BYP(TT)
TOTAL 2496 2184 70 331 53 268
MEAN 48 96% 3% 16% 2% 16% 51
RANGE 6–221 75–100% 0–14% 0–43% 0–11% 0–50% 3–120
S.D. 42 5 4 11 2 14 25
AAB 5 Axillo-axillary bypass; CSB 5 Carotid-subclavian bypass; TRP 5 Carotid-subclavian transposition; BYP 5 Other bypass procedure; VL 5 Vertebral ligation; EAC 5
Endarterectomy; TT 5 Transthoracic approach; Ref. 5 Reference number; F/U(mo.) 5 mean follow-up (months).
dures are still associated with significant risks including a
rate of stroke of approximately 3% and mortality of 2%.
Benefits of percutaneous treatment. Percutaneous
catheter-based treatment has become an alternative to
surgery because it is less invasive, has a lower complication
rate and may result in a shorter hospitalization. Several
earlier studies have reported initial success and patency rates
with balloon angioplasty similar to surgery (15–20). Stent-
ing, when used in addition to balloon dilatation, may reduce
the risk of embolization and achieve anatomically and
physiologically superior results. Indeed, analysis of the
literature (72–77) suggests that complications are fewer and
the success of revascularization similar, if not better. The
treatment of total occlusions, thought to be a limitation of
percutaneous treatment, is now possible (72). Good results
are also being reported with stent-based treatment of carotid
stenoses (78).
Our series consists of all patients with subclavian and
brachiocephalic obstruction identified by or referred to our
unit over the course of 48 months; all were treated using
percutaneous techniques employing stents to revascularize
patients with symptomatic stenoses and occlusions. There
was uniform success and few complications—notably no
transient or permanent neurological deficits and no deaths.
Follow-up evaluation was standardized and objective—
100% patency of the treated segments was confirmed by
noninvasive testing. This format ensured that occlusions or
restenoses were not masked by the development of collateral
circulation. The results of percutaneous stenting compare
favorably with the surgical experience. Specifically, technical
success (97% vs. 96%) and patency (97% at 20 months vs.
84% at 51 months) are similar while the incidence of the
major complications of stroke and procedure-related death
are lower in the stent group.
Limitations of this study. Care must be taken in drawing
conclusions from the published experience of any procedure
for brachiocephalic and subclavian revascularization. There
are no prospective randomized clinical trials comparing the
two forms of therapy; all published series are descriptions of
experience. Since the reported series are not themselves
controlled trials, a combined metaanalysis is not appropri-
ate. Comparison is also confounded by the lack of similar
patient selection criteria, inclusion bias or recorded end-
points. It is also inappropriate to combine the surgical series
into one group as “historical controls” and the stented
patients into a second “treatment group” and to compare
statistically their mean characteristics.
The length of time over which the surgical literature has
been developed gives rise to questions of whether it is
appropriate to compare the surgical techniques of the past
few decades with the percutaneous treatment of the past few
years. Though surgical techniques have improved, opera-
tions still often involve general anesthesia, direct manipu-
lation or clamping of the carotid (in the case of carotid-
subclavian bypass) or open-chest procedures—perhaps
accouting for the potentially higher rates of overall compli-
cation and stroke with surgical treatment. When only the
surgical series from the last ten years are considered, the
rates of overall complications, stroke and death still appear
to be greater than those of stenting.
Conclusions. Considering our clinical results and the
available published data, surgical therapy does not appear to
provide outcomes superior to those of percutaneous stent-
ing. The absence of stroke or death in the stent series
strongly suggests that, in experienced hands, stenting may
achieve its outcomes at a lower procedural risk than surgical
therapy. Until a large-scale prospective randomized trial can
be performed, we believe percutaneous stenting should be
considered the preferred therapy for the treatment of aortic
arch vessel obstructive lesions.
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